Stock UniverseDerived research view · source repositories remain read-only

Tonix Pharmaceuticals Holding Corp. (TNXP)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.66
Global Rank
3148
Market Cap
178.73M
Latest Close
11.07
RS Composite
-36.03% · G#3144

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-24.64%
3M
-17.70%
6M
-37.74%
1Y
-71.58%
3Y
-99.81%
5Y
-100.00%
10Y
-100.00%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 475.53K · 30-day average: 439.18K · Max drawdown over stored range: -100.00%

Research Snapshot

Relative Strength vs SPX

RS Composite-36.03%
20D RS-19.36%
60D RS-29.79%
120D RS-50.60%
Global RS Rank3144 · 6.29% percentile
Watch+Speculative RS Rank1939 · 7.53% percentile
Group ScopeWatch+Speculative
Primary RS Rank397 · 13.32% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank398 / 701
Primary Percentile43.37
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for TNXP.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0007.76810.09413.107
Revenue Growth (YoY)2900%2900%2900%2900%29.943%29.849%
Gross Profit0003.0272.329
Operating Income-50.511-92.312-112.091-118.38-77.744
Free Cash Flow-57.13-110.864-146.2-109.898-61.045-103.213
Free Cash Flow Per Share29292929-82.903-12.126559012364478
EPS (Diluted) GAAP29292929-176.598007
EPS Growth
EPS Non-GAAP
Gross Margin2900%2900%2900%38.968%23.073%49.34%
Operating Margin2900%2900%2900%-1523.944%-770.2%-959.0524%
Profit Margin2900%2900%2900%-1501.777%-1288.25%-946.2196%
Free Cash Flow Margin2900%2900%2900%-1414.753%-604.765%-787.4647%
Shares Outstanding (Diluted)00000.73638.5113
Shares Change (YoY)285.228%220.612%334.139%9191.344%1055.897%

SEC Quarterly Fundamentals

No processed quarterly rows for TNXP.